Table 3.

Topics of Educational Interest Among All Healthcare Providers

	All Healthcare Providers
Please indicate which of the following CME topics would be important in helping you to better manage your patients who are at risk for CINV.	Strongly Agree, %	Agree, %	Disagree, %
Adhere/interpret the CINV guidelines	41	55	5
Communicate with patients about CINV	43	51	6
Differentiate between CINV therapies	46	50	5
Integrate novel therapies for the prevention and treatment of CINV	47	48	5
Keep up to date on emerging clinical data in CINV	48	48	4
Options for managing radiation- and opioid-induced CINV	44	52	5
Prevent/manage breakthrough nausea and vomiting	54	42	4
Prevent/manage CINV in patients undergoing bone marrow transplant	35	51	14
Prevent/manage CINV when administering multiday chemotherapy	47	47	6
Prevent/manage nausea specifically	46	50	5
Understand barriers to adherence with antiemetic guidelines	42	53	5
Understand the consequences of untreated/uncontrolled CINV for the patient (and caregivers)	44	51	6
Understand the pharmacoeconomic consequences of untreated/uncontrolled CINV	42	51	7
Overcoming challenging CINV patient scenarios	36	58	6
Personalizing CINV treatment	42	53	5
Selecting the most effective therapies to prevent CINV	48	49	3
Stratifying patients according to their risk for CINV	35	59	7
Treating refractory CINV	44	51	4
Understanding the mechanism of CINV therapies	39	55	6
Understanding the patient-related factors that increase the risk of CINV	42	53	5
Understanding the pathophysiology of CINV	40	53	7
Understanding the side-effect profile of CINV therapies	41	54	5
Utilizing standing orders for CINV	33	56	11
Working as a multidisciplinary team to overcome CINV	41	53	7